Nu Skin Enterprises Inc. (NYSE: NUS) has reported a loss for its first fiscal quarter (ending March 31) of $-0.01 versus $0.23 for the same period a year ago — a decline of -104%. This performance was $-0.12 short of the consensus estimate of $0.10. E.P.S. were $-0.06 for the latest four quarters through March 31 versus $1.56 for the same period a year ago — a decline of -104%.
Recent Price Action
On 5/8/24, Nu Skin Enterprises Inc. (NYSE: NUS) stock increased 1.4%, closing at $12.42. This advance was accompanied by normal trading volume. The stock has risen 5.6% during the last week but has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, NUS is expected to continue to be a Value Builder.
Nu Skin Enterprises has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Nu Skin Enterprises has a slightly positive Appreciation Score of 64 but a very low Power Rating of 5, with the Negative Value Trend Rating the result.
Rating Review
In light of this discouraging new earnings information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment